[go: up one dir, main page]

NO822722L - PROCEDURE FOR THE PREPARATION OF BENZAZEPIN-2-ONER. - Google Patents

PROCEDURE FOR THE PREPARATION OF BENZAZEPIN-2-ONER.

Info

Publication number
NO822722L
NO822722L NO822722A NO822722A NO822722L NO 822722 L NO822722 L NO 822722L NO 822722 A NO822722 A NO 822722A NO 822722 A NO822722 A NO 822722A NO 822722 L NO822722 L NO 822722L
Authority
NO
Norway
Prior art keywords
oner
benzazepin
procedure
preparation
Prior art date
Application number
NO822722A
Other languages
Norwegian (no)
Other versions
NO161558B (en
NO161558C (en
Inventor
Jeffrey W H Watthey
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NO822722L publication Critical patent/NO822722L/en
Publication of NO161558B publication Critical patent/NO161558B/en
Publication of NO161558C publication Critical patent/NO161558C/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16Benzazepines; Hydrogenated benzazepines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06086Dipeptides with the first amino acid being basic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO822722A 1981-08-11 1982-08-10 ANALOGY PROCEDURE FOR THE PREPARATION OF ANTIHYPERTENSIVE BENZAZEPIN-2-ONER. NO161558C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29190781A 1981-08-11 1981-08-11
US31986381A 1981-11-09 1981-11-09

Publications (3)

Publication Number Publication Date
NO822722L true NO822722L (en) 1983-02-14
NO161558B NO161558B (en) 1989-05-22
NO161558C NO161558C (en) 1989-08-30

Family

ID=26967047

Family Applications (1)

Application Number Title Priority Date Filing Date
NO822722A NO161558C (en) 1981-08-11 1982-08-10 ANALOGY PROCEDURE FOR THE PREPARATION OF ANTIHYPERTENSIVE BENZAZEPIN-2-ONER.

Country Status (22)

Country Link
EP (1) EP0072352B1 (en)
KR (3) KR890003425B1 (en)
AR (3) AR240806A1 (en)
AT (1) ATE18397T1 (en)
AU (1) AU561395B2 (en)
CA (1) CA1196636A (en)
CY (1) CY1403A (en)
DD (1) DD202546A5 (en)
DE (1) DE3269625D1 (en)
DK (1) DK157881C (en)
ES (6) ES514856A0 (en)
FI (1) FI76074C (en)
GB (1) GB2103614B (en)
GR (1) GR77256B (en)
HK (1) HK93387A (en)
HU (1) HU189628B (en)
IE (1) IE53668B1 (en)
IL (1) IL66501A (en)
NL (1) NL930112I2 (en)
NO (1) NO161558C (en)
NZ (1) NZ201555A (en)
PT (1) PT75395B (en)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3242599A1 (en) * 1982-11-18 1984-05-24 Dr. Karl Thomae Gmbh, 7950 Biberach NEW BENZAZEPINE DERIVATIVES, THEIR PRODUCTION AND THEIR USE AS MEDICINAL PRODUCTS
US4473575A (en) * 1982-07-19 1984-09-25 Ciba-Geigy Corporation 3-Amino-(1)-benzazepin-2-one-1-alkanoic acids
EP0107095B1 (en) * 1982-09-30 1987-09-09 Merck & Co. Inc. 1-n-alkylcarboxy-benzofused lactams useful as antihypertensive agents
US4575503A (en) * 1983-02-10 1986-03-11 Ciba-Geigy Corporation 3-Amino-[1]-benzazepin-2-one-1-alkanoic acids
US4564612A (en) * 1983-04-22 1986-01-14 Takeda Chemical Industries, Ltd. Condensed, seven-membered ring compounds and their use
US4539150A (en) * 1983-06-29 1985-09-03 Mitsui Toatsu Chemicals, Inc. Benzothiazepine derivatives and their methods of preparation
JPS608284A (en) * 1983-06-29 1985-01-17 Mitsui Toatsu Chem Inc Benzothiazepine derivative and its preparation
IL72523A (en) * 1983-08-12 1988-06-30 Takeda Chemical Industries Ltd 3-amino-4-oxo-2,3,4,5-tetrahydro-1,5-benzoxazepine derivatives,their production and pharmaceutical compositions containing them
US4638000A (en) * 1983-08-12 1987-01-20 Takeda Chemical Industries, Ltd. Condensed seven-membered ring compounds, their production and use
AU570710B2 (en) * 1983-08-12 1988-03-24 Takeda Chemical Industries Ltd. 4-oxo-2, 3, 4, 5-tetrahydro-1, 5-benzoxazepine derivatives
EP0166354B1 (en) * 1984-06-26 1992-08-05 Merck & Co. Inc. Benzofused lactam compounds and pharmaceutical compositions containing them
CA1266647A (en) * 1984-06-26 1990-03-13 William H. Parsons Benzofused lactams useful as antihypertensive agents and as cholecystokinin antagonists
EP0166357A3 (en) * 1984-06-26 1988-10-26 Merck & Co. Inc. Benzofused lactams and pharmaceutical compositions containing them
US4785089A (en) * 1985-06-13 1988-11-15 Ciba-Geigy Corporation Novel sulfonic acid esters and their preparation
DE3704661A1 (en) * 1987-02-14 1988-08-25 Hoechst Ag FELECTED AZEPINONE AND AZOCINONE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, THEIR CONTAINERS AND THEIR USE, AND INTERMEDIATE PRODUCTS IN THEIR PRODUCTION
EP0322779A3 (en) * 1987-12-29 1991-05-08 Yoshitomi Pharmaceutical Industries, Ltd. Benzolactam compounds and pharmaceutical uses thereof
TW197945B (en) * 1990-11-27 1993-01-11 Hoechst Ag
GB9100028D0 (en) * 1991-01-02 1991-02-20 Ici Plc Compounds
GB9212308D0 (en) * 1992-06-10 1992-07-22 Ici Plc Therapeutic compositions
US5504080A (en) * 1992-10-28 1996-04-02 Bristol-Myers Squibb Co. Benzo-fused lactams
US5610153A (en) * 1992-12-11 1997-03-11 Ciba-Geigy Corporation Benzazepinone derivatives
GB9310075D0 (en) * 1993-05-17 1993-06-30 Fujisawa Pharmaceutical Co New mercapto-amide derivatives,processes for the preparation thereof and pharmaceutical composition comprising the same
GB9311948D0 (en) * 1993-06-10 1993-07-28 Zeneca Ltd Substituted nitrogen heterocycles
US5801168A (en) * 1994-06-09 1998-09-01 Zeneca Limited Substituted nitrogen heterocycles
US5597922A (en) * 1994-07-29 1997-01-28 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon Glycine receptor antagonist pharmacophore
CA2391498A1 (en) * 1999-11-18 2001-05-25 Antexpharma, Inc. Substituted 1-benzazepines and derivatives thereof
CA2668823A1 (en) 2000-12-27 2002-07-04 Merck Patent Gesellschaft Mit Beschraenkter Haftung Process for the preparation of .alpha.-aminosubstituted carboxylic acid amides
WO2002076375A2 (en) 2001-03-27 2002-10-03 Ranbaxy Laboratories Limited Process for the preparation of benazepril
EP1443919A4 (en) 2001-11-16 2006-03-22 Bristol Myers Squibb Co Dual inhibitors of adipocyte fatty acid binding protein and keratinocyte fatty acid binding protein
US20050107359A1 (en) * 2002-07-26 2005-05-19 Van Der Schaaf Paul A. Crystalline polymorphic and amorphous forms of benazepril hydrochloride
KR100710548B1 (en) * 2002-12-26 2007-04-24 에스케이 주식회사 (s) -3-amino-2,3,4,5-tetrahydro-2-oxo-1H-1-benzazepine-1-acetic acid and a method for producing an ester compound thereof
US7459474B2 (en) 2003-06-11 2008-12-02 Bristol-Myers Squibb Company Modulators of the glucocorticoid receptor and method
US8080579B2 (en) 2005-10-03 2011-12-20 The Regents Of The University Of Michigan Compositions and methods for treatment of inflammatory bowel disease
US7592461B2 (en) 2005-12-21 2009-09-22 Bristol-Myers Squibb Company Indane modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
US7968577B2 (en) 2006-11-01 2011-06-28 Bristol-Myers Squibb Company Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
CN101573340A (en) 2006-11-01 2009-11-04 百时美施贵宝公司 Modulators of glucocorticoid receptor AP-1 and/or NF-kB activity and uses thereof
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
ES2559319T3 (en) 2007-06-04 2016-02-11 Synergy Pharmaceuticals Inc. Guanylate cliclas agonists useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US7828840B2 (en) 2007-11-15 2010-11-09 Med Institute, Inc. Medical devices and methods for local delivery of angiotensin II type 2 receptor antagonists
CA2726917C (en) 2008-06-04 2018-06-26 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
JP2011525537A (en) 2008-06-24 2011-09-22 ブリストル−マイヤーズ スクイブ カンパニー Cyclopentathiophene modulators of glucocorticoid receptor, AP-1, and / or NF-κB activity and uses thereof
EP3241839B1 (en) 2008-07-16 2019-09-04 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
EP2968439A2 (en) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
CA2905438A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
EA201592263A1 (en) 2013-06-05 2016-05-31 Синерджи Фармасьютикалз, Инк. ULTRASCULAR AGONISTS OF GUANYLACYCLASE C, METHOD OF THEIR RECEIVING AND USING
US9593113B2 (en) 2013-08-22 2017-03-14 Bristol-Myers Squibb Company Imide and acylurea derivatives as modulators of the glucocorticoid receptor
CN113292495B (en) * 2021-06-18 2022-09-13 迪嘉药业集团有限公司 Synthesis method of (S) -amino compound

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3395150A (en) * 1965-02-26 1968-07-30 Squibb & Sons Inc Benzothiazepine carboxamides and derivatives thereof
GB1305278A (en) * 1970-03-12 1973-01-31

Also Published As

Publication number Publication date
CY1403A (en) 1987-12-18
NL930112I1 (en) 1993-10-18
EP0072352A1 (en) 1983-02-16
NL930112I2 (en) 1996-11-01
EP0072352B1 (en) 1986-03-05
HU189628B (en) 1986-07-28
KR890003425B1 (en) 1989-09-20
FI76074C (en) 1988-09-09
ES8502974A1 (en) 1985-02-01
DD202546A5 (en) 1983-09-21
HK93387A (en) 1987-12-18
ES514856A0 (en) 1985-02-01
FI822770A0 (en) 1982-08-09
ES526887A0 (en) 1986-04-16
KR900001190B1 (en) 1990-02-28
ES526886A0 (en) 1985-11-01
GB2103614B (en) 1984-11-21
KR840001139A (en) 1984-03-28
AR240807A1 (en) 1991-02-28
AR241222A1 (en) 1992-02-28
AU8701482A (en) 1983-05-12
GR77256B (en) 1984-09-11
DK157881C (en) 1990-07-23
ES526888A0 (en) 1985-04-16
AR240806A1 (en) 1991-02-28
AR240806A2 (en) 1991-02-28
CA1196636A (en) 1985-11-12
DK358682A (en) 1983-02-12
DE3269625D1 (en) 1986-04-10
GB2103614A (en) 1983-02-23
DK157881B (en) 1990-02-26
ES8606285A1 (en) 1986-04-16
IL66501A0 (en) 1982-12-31
PT75395A (en) 1982-09-01
ES8601142A1 (en) 1985-11-01
IL66501A (en) 1987-10-20
ES526889A0 (en) 1986-02-01
IE53668B1 (en) 1989-01-04
ES530658A0 (en) 1985-12-01
ES8604523A1 (en) 1986-02-01
FI822770L (en) 1983-02-12
AR240807A2 (en) 1991-02-28
AU561395B2 (en) 1987-05-07
PT75395B (en) 1985-11-15
KR900001191B1 (en) 1990-02-28
NO161558B (en) 1989-05-22
ATE18397T1 (en) 1986-03-15
NO161558C (en) 1989-08-30
NZ201555A (en) 1986-06-11
ES8504728A1 (en) 1985-04-16
IE821929L (en) 1983-02-11
FI76074B (en) 1988-05-31
ES8602682A1 (en) 1985-12-01

Similar Documents

Publication Publication Date Title
NO822722L (en) PROCEDURE FOR THE PREPARATION OF BENZAZEPIN-2-ONER.
NO821087L (en) PROCEDURE FOR THE PREPARATION OF CYCLOBUTAN DERIVATIVES.
NO821586L (en) PROCEDURE FOR THE PREPARATION OF 1,2-DIAMINO-CYCLOBUTEN-3,4-DIONE.
NO159667C (en) PROCEDURE FOR THE PREPARATION OF PICKHOST TOXIDE.
NO158752C (en) PROCEDURE FOR THE PREPARATION OF ETHANOL.
NO157861C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF AMINOPYRIDAZINES.
NO820959L (en) PROCEDURE FOR THE PREPARATION OF ACYL-QUINOLINO DERIVATIVES
NO158136C (en) PROCEDURE FOR THE PREPARATION OF TIADIAZOLD DERIVATIVES.
NO855067L (en) PROCEDURE FOR THE PREPARATION OF N-FORMYL-ALFA-ASPARTYL-PHENYLALANINE.
NO155693C (en) PROCEDURE FOR THE PREPARATION OF EBURNAMONIN DERIVATIVES.
NO822634L (en) PROCEDURE FOR THE MANUFACTURE OF CEFEM DERIVATIVES.
FI822408A7 (en) Method for the preparation of amidobenzamides.
NO853066L (en) PROCEDURE FOR THE PREPARATION OF 3-CARBONYL-1-AMINOALKYL-1H-INDOLES.
NO812519L (en) PROCEDURE FOR THE PREPARATION OF CHOLESTERASE.
NO823884L (en) PROCEDURE FOR THE PREPARATION OF 1,2-DICHLORETHANE
NO163061C (en) PROCEDURE FOR THE PREPARATION OF PERROMANGANE.
NO162018C (en) PROCEDURE FOR THE PREPARATION OF 4-METHYL-5-ALKYLTYOMETHYLIMIDAZOLES.
NO801142L (en) PROCEDURE FOR THE PREPARATION OF CHLORODIOXIDE.
NO154636C (en) PROCEDURE FOR THE PREPARATION OF CRYSTALLINIC AMINOCYCLITOL DERIVATIVES.
NO165637C (en) PROCEDURE FOR THE PREPARATION OF ETHOXYLED LIGINITE.
NO157422C (en) PROCEDURE FOR THE PREPARATION OF ANTI-T-Lymphocyte GLOBULIN.
ES510963A0 (en) PROCEDURE FOR THE PREPARATION OF ALCOXIAMINOHIDRIDOSILANOS.
NO810114L (en) PROCEDURE FOR THE PREPARATION OF KIJANIMICIN.
ES517428A0 (en) PROCEDURE FOR THE PREPARATION OF BENCILIDENIC DERIVATIVES.
NO159268C (en) PROCEDURE FOR THE PREPARATION OF 3-PICOLINE.

Legal Events

Date Code Title Description
MK1K Patent expired

Free format text: EXPIRED IN AUGUST 2002